The DOI matches its Crossref record; 48 of the 48 references it cites were found in a registry or an index.
Activated Wnt/ß-catenin signaling in melanoma is associated with decreased proliferation in patient tumors and a murine melanoma model
Open accessAbstract
This study demonstrates that in malignant melanoma, elevated levels of nuclear ß-catenin in both primary tumors and metastases correlate with reduced expression of a marker of proliferation and with improved survival, in contrast to colorectal cancer. The reduction in proliferation observed in vivo is recapitulated in B16 murine melanoma cells and in human melanoma cell lines cultured in vitro with either WNT3A or small-molecule activators of ß-catenin signaling. Consistent with these results, B16 melanoma cells expressing WNT3A also exhibit decreased tumor size and decreased metastasis when implanted into mice. Genome-wide transcriptional profiling reveals that WNT3A up-regulates genes implicated in melanocyte differentiation, several of which are down-regulated with melanoma progression. These findings suggest that WNT3A can mediate transcriptional changes in melanoma cells in a manner reminiscent of the known role of Wnt/ß-catenin signaling in normal melanocyte development, thereby altering melanoma cell fate to one that may be less proliferative and potentially less aggressive. Our results may explain the observed loss of nuclear ß-catenin with melanoma progression in human tumors, which could reflect a dysregulation of cellular differentiation through a loss of homeostatic Wnt/ß-catenin signaling.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A Third-Generation Lentivirus Vector with a Conditional Packaging System
Dull, T., Zufferey, R., Kelly, M., Mandel, R. J., Nguyen, M., Trono, D., & Naldini, L. (1998) · Journal of Virology · doi:10.1128/jvi.72.11.8463-8471.1998 · Cited by 3,341
Molecular classification of cutaneous malignant melanoma by gene expression profiling
Bittner, M., Meltzer, P., Chen, Y., Jiang, Y., Seftor, E., Hendrix, M., Radmacher, M., Simon, R., Yakhini, Z., Ben-Dor, A., et al. (2000) · Nature · doi:10.1038/35020115 · Cited by 1,990
WNT and β-catenin signalling: diseases and therapies
Moon, R. T., Kohn, A. D., Ferrari, G. V. D., & Kaykas, A. (2004) · Nature Reviews Genetics · doi:10.1038/nrg1427 · Cited by 1,763
Self-citationJho, E.-H., Zhang, T., Domon, C., Joo, C.-K., Freund, J.-N., & Costantini, F. (2002) · Molecular and Cellular Biology · doi:10.1128/mcb.22.4.1172-1183.2002 · Cited by 1,678
Caught up in a Wnt storm: Wnt signaling in cancer
Giles, R. H., van Es, J. H., & Clevers, H. (2003) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/s0304-419x(03)00005-2 · Cited by 1,482
Veeman, M. T., Axelrod, J. D., & Moon, R. T. (2003) · Developmental Cell · doi:10.1016/s1534-5807(03)00266-1 · Cited by 1,359
Self-citationStabilization of β-Catenin by Genetic Defects in Melanoma Cell Lines
Rubinfeld, B., Robbins, P., El-Gamil, M., Albert, I., Porfiri, E., & Polakis, P. (1997) · Science · doi:10.1126/science.275.5307.1790 · Cited by 1,223
Wnt5a signaling directly affects cell motility and invasion of metastatic melanoma
Weeraratna, A. T., Jiang, Y., Hostetter, G., Rosenblatt, K., Duray, P., Bittner, M., & Trent, J. M. (2002) · Cancer Cell · doi:10.1016/s1535-6108(02)00045-4 · Cited by 959
Rijsewijk, F., Schuermann, M., Wagenaar, E., Parren, P., Weigel, D., & Nusse, R. (1987) · Cell · doi:10.1016/0092-8674(87)90038-9 · Cited by 931
Management of Cutaneous Melanoma
Tsao, H., Atkins, M. B., & Sober, A. J. (2004) · New England Journal of Medicine · doi:10.1056/nejmra041245 · Cited by 855
Automated subcellular localization and quantification of protein expression in tissue microarrays
Camp, R. L., Chung, G. G., & Rimm, D. L. (2002) · Nature Medicine · doi:10.1038/nm791 · Cited by 764
Self-citationSynergy Between Tumor Suppressor APC and the β-Catenin-Tcf4 Target Tcf1
Roose, J., Huls, G., Beest, M. V., Moerer, P., Horn, K. V. D., Goldschmeding, R., Logtenberg, T., & Clevers, H. (1999) · Science · doi:10.1126/science.285.5435.1923 · Cited by 456
Wilms Tumor Suppressor WTX Negatively Regulates WNT/ß-Catenin Signaling
Major, M. B., Camp, N. D., Berndt, J. D., Yi, X., Goldenberg, S. J., Hubbert, C., Biechele, T. L., Gingras, A.-C., Zheng, N., MacCoss, M. J., et al. (2007) · Science · doi:10.1126/science/1141515 · Cited by 405
Self-citationDown-regulation of the novel gene melastatin correlates with potential for melanoma metastasis.
Duncan, L. M., Deeds, J. D., Hunter, J., Shao, J., Holmgren, L. M., Woolf, E. A., Tepper, R. I., & Shyjan, A. W. (1998) · PubMed · Cited by 401
Dissanayake, S. K., Wade, M., Johnson, C. E., O'Connell, M. P., Leotlela, P. D., French, A. D., Shah, K. V., Hewitt, K. J., Rosenthal, D. T., Indig, F. E., et al. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m700075200 · Cited by 374
Self-citationMurakami, T., Maki, W. C., Cardones, A. R., Fang, H., Tun-Kyi, A., Nestle, F. O., & Hwang, S. T. (2002) · PubMed · Cited by 347
Self-citationAn X Chromosome Gene, WTX , Is Commonly Inactivated in Wilms Tumor
Rivera, M. N., Kim, W. J., Wells, J., Driscoll, D. R., Brannigan, B. W., Han, M., Kim, J. C., Feinberg, A. P., Gerald, W. L., Vargas, S. O., et al. (2007) · Science · doi:10.1126/science.1137509 · Cited by 342
Delmas, V., Beermann, F., Martinozzi, S., Carreira, S., Ackermann, J., Kumasaka, M., Denat, L., Goodall, J., Luciani, F., Viros, A., et al. (2007) · Genes & Development · doi:10.1101/gad.450107 · Cited by 311
Widlund, H. R., Horstmann, M. A., Price, E. R., Cui, J., Lessnick, S. L., Wu, M., He, X., & Fisher, D. E. (2002) · The Journal of Cell Biology · doi:10.1083/jcb.200202049 · Cited by 291
Ryu, B., Kim, D. S., DeLuca, A. M., & Alani, R. M. (2007) · PLoS ONE · doi:10.1371/journal.pone.0000594 · Cited by 289
Rimm, D. L., Caca, K., Hu, G., Harrison, F. B., & Fearon, E. R. (1999) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)65278-9 · Cited by 283
Self-citationDorsky, R. I., Raible, D. W., & Moon, R. T. (2000) · Genes & Development · doi:10.1101/gad.14.2.158 · Cited by 279
Self-citationKoesters, R., Ridder, R., Kopp‐Schneider, A., Betts, D. R., Adams, V., Niggli, F. K., Briner, J., & Doeberitz, M. V. K. (1999) · PubMed · Cited by 266
Witze, E. S., Litman, E. S., Argast, G. M., Moon, R. T., & Ahn, N. G. (2008) · Science · doi:10.1126/science.1151250 · Cited by 244
Self-citationNeural Crest Stem and Progenitor Cells
Crane, J. F., & Trainor, P. A. (2006) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev.cellbio.22.010305.103814 · Cited by 235
The Transcription Network Regulating Melanocyte Development and Melanoma
Vance, K. W., & Goding, C. R. (2004) · Pigment Cell Research · doi:10.1111/j.1600-0749.2004.00164.x · Cited by 209
Bachmann, I. M., Straume, O., Puntervoll, H. E., Kalvenes, M. B., & Akslen, L. A. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-0011 · Cited by 188
Melanoma Stem Cells: The Dark Seed of Melanoma
Zabierowski, S. E., & Herlyn, M. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2007.15.5465 · Cited by 180
WNT5A Expression Increases during Melanoma Progression and Correlates with Outcome
Da Forno, P. D., Pringle, J. H., Hutchinson, P., Osborn, J., Huang, Q., Potter, L., Hancox, R. A., Fletcher, A., & Saldanha, G. S. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-5104 · Cited by 170
Lugli, A., Zlobec, I., Minoo, P., Baker, K., Tornillo, L., Terracciano, L., & Jass, J. R. (2007) · Histopathology · doi:10.1111/j.1365-2559.2007.02620.x · Cited by 154
Prognostic and Diagnostic Significance of β-Catenin Nuclear Immunostaining in Colorectal Cancer
Wong, S. C. C., Lo, E. S. F., Lee, K. C., Chan, J. K. C., & Hsiao, W. L. W. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-0157-03 · Cited by 151
Loss of beta-catenin expression associated with disease progression in malignant melanoma
Kageshita, T., Hamby, C. V., Ishihara, T., Matsumoto, K., Saida, T., & Ono, T. (2001) · British Journal of Dermatology · doi:10.1046/j.1365-2133.2001.04336.x · Cited by 138
REIFENBERGER, J., Knobbe-Thomsen, C. B., Wolter, M., Blaschke, B., Schulte, K. W., Pietsch, T., Ruzicka, T., & Reifenberger, G. (2002) · International Journal of Cancer · doi:10.1002/ijc.10512 · Cited by 131
Watabe, K., Ito, A., Asada, H., Endo, Y., Kobayashi, T., Nakamoto, K., Itami, S., Takao, S., Shinomura, Y., Aikou, T., et al. (2001) · Japanese Journal of Cancer Research · doi:10.1111/j.1349-7006.2001.tb01076.x · Cited by 127
Genetic and epigenetic alterations of the APC gene in malignant melanoma
Worm, J., Christensen, C., Grønbæk, K., Tulchinsky, E. M., & Guldberg, P. (2004) · Oncogene · doi:10.1038/sj.onc.1207647 · Cited by 125
Influence of the Microenvironment on Melanoma Cell Fate Determination and Phenotype
Postovit, L.-M. M., Seftor, E. A., Seftor, R. E. B., et al. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-0731 · Cited by 119
Defining the Conditions for the Generation of Melanocytes from Human Embryonic Stem Cells
Fang, D., Leishear, K., Nguyen, T. K., Finko, R., Cai, K., Fukunaga, M., Li, L., Brafford, P. A., Kulp, A. N., Xu, X., et al. (2006) · Stem Cells · doi:10.1634/stemcells.2005-0414 · Cited by 114
Omholt, K., Platz, A., Ringborg, U. K., & Hansson, J. (2001) · International Journal of Cancer · doi:10.1002/ijc.1270 · Cited by 112
Weidinger, G., & Moon, R. T. (2003) · The Journal of Cell Biology · doi:10.1083/jcb.200307181 · Cited by 112
Self-citationMælandsmo, G. M., Holm, R., Nesland, J. M., Fodstad, Ø., & Flørenes, V. A. (2003) · PubMed · Cited by 96
A Wnt-er Wonderland—The complexity of Wnt signaling in melanoma
Weeraratna, A. T. (2005) · Cancer and Metastasis Reviews · doi:10.1007/s10555-005-1574-z · Cited by 92
β‐Catenin in the Melanocyte Lineage
Larue, L., Kumasaka, M. Y., & Goding, C. R. (2003) · Pigment Cell Research · doi:10.1034/j.1600-0749.2003.00050.x · Cited by 88
Generation and analysis of melanoma SAGE libraries: SAGE advice on the melanoma transcriptome
Weeraratna, A. T., Becker, D., Carr, K. M., Duray, P. H., Rosenblatt, K. P., Yang, S. W., Chen, Y., Bittner, M. L., Strausberg, R. L., Riggins, G. J., et al. (2004) · Oncogene · doi:10.1038/sj.onc.1207337 · Cited by 72
Prognostic Significance of Cadherin-Based Adhesion Molecules in Cutaneous Malignant Melanoma
Kreizenbeck, G. M., Berger, A. J., Subtil, A., Rimm, D. L., & Rothberg, B. E. G. (2008) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-07-2729 · Cited by 68
Self-citationA survival–stratification model of human colorectal carcinomas with β‐catenin and p27kip1
Cheah, P. Y., Choo, P. H., Yao, J. T. D., Eu, K. W., & Seow‐Choen, F. (2002) · Cancer · doi:10.1002/cncr.10986 · Cited by 62
WNTS and WNT receptors as therapeutic tools and targets in human disease processes
Andy, J. C. (2006) · Frontiers in bioscience · doi:10.2741/2074 · Cited by 56
Mutations in exon 3 of the β-catenin gene are rare in melanoma cell lines
Pollock, P. M., & Hayward, N. K. (2002) · Melanoma Research · doi:10.1097/00008390-200204000-00013 · Cited by 42
Hammock, L., Cohen, C., Carlson, G. W., Murray, D. L., Ross, J. S., Sheehan, C. E., Nazir, T. M., & Carlson, J. A. (2006) · Journal of Cutaneous Pathology · doi:10.1111/j.1600-0560.2006.00501.x · Cited by 38
Cited by
Zhan, T., Rindtorff, N., & Boutros, M. (2017) · Oncogene · doi:10.1038/onc.2016.304 · Cited by 2,626
WNT signalling pathways as therapeutic targets in cancer
Anastas, J. N., & Moon, R. T. (2013) · Nature Reviews Cancer · doi:10.1038/nrc3419 · Cited by 1,911
Self-citationCan we safely target the WNT pathway?
Kahn, M. (2014) · Nature Reviews Drug Discovery · doi:10.1038/nrd4233 · Cited by 1,034
The regulation of β-catenin activity and function in cancer: therapeutic opportunities
Shang, S., Hua, F., & Hu, Z.-W. (2017) · Oncotarget · doi:10.18632/oncotarget.15687 · Cited by 641
Kaur, A., Webster, M. R., Marchbank, K., Behera, R., Ndoye, A., Kugel, C. H., Dang, V. M., Appleton, J., O’Connell, M. P., Cheng, P., et al. (2016) · Nature · doi:10.1038/nature17392 · Cited by 398
Retracted
Metadata
- Authors
- Chien, A. J., Moore, E. C., Lonsdorf, A. S., Kulikauskas, R. M., Rothberg, B. G., Berger, A. J., Major, M. B., Hwang, S. T., Rimm, D. L., & Moon, R. T.
- Venue
- Proceedings of the National Academy of Sciences
- Published
- 2009-01-27
- Volume
- 106
- Issue
- 4
- Pages
- 1193-1198
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- OpenAlex
- W2104877706
- Cited by
- 332
- References
- 48
- FWCI
- 10.20
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.